scholarly journals Percutaneous Balloon Pericardiotomy (PBP) Revisited: A Case Report and Review of Literature

2020 ◽  
Vol 2020 ◽  
pp. 1-3
Author(s):  
Raed Aqel ◽  
Muawiyah Elqadi ◽  
Ahmad Hammouri ◽  
Mohammad S. Alqadi
Keyword(s):  
Case Report ◽  
Pericardial Effusion ◽  
Stage Iv ◽  
Shortness Of Breath ◽  
Review Of Literature ◽  
Pericardial Window ◽  
Severe Respiratory Distress ◽  
Case Presentation ◽  
Percutaneous Balloon ◽  
Recurrent Pericardial Effusion

Background. A Percutaneous Balloon Pericardiotomy (PBP) procedure is a reemerging nonsurgical technique that helps in preventing the reaccumulation of pericardial effusion. It is done percutaneously without general anaesthesia. It has been proved to be effective in alleviating and preventing recurrent pericardial effusion. Case Presentation. We reported a 52-year-old male with stage IV adenocarcinoma causing recurrent pericardial effusion. The patient experienced a worsening shortness of breath. A surgical pericardial window was denied by the surgery team secondary to severe respiratory distress; subsequently, the patient underwent Percutaneous Balloon Pericardiotomy. Conclusion. Percutaneous Balloon Pericardiotomy is efficacious and safe when done by well-trained physicians. We think it should be considered as a preferred treatment modality in most sicker patients with recurrent pericardial effusion.

Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab

Immunotherapy ◽  
2019 ◽  
Vol 11 (18) ◽  
pp. 1533-1540 ◽  
Author(s):  
Abdul Moiz Khan ◽  
Ayesha Munir ◽  
Vimala Thalody ◽  
Mohamed Khalid Munshi ◽  
Syed Mehdi
Keyword(s):  
Pericardial Effusion ◽  
Lung Adenocarcinoma ◽  
Cardiac Tamponade ◽  
Stage Iv ◽  
High Dose ◽  
Shortness Of Breath ◽  
Pericardial Window ◽  
Large Pericardial Effusion ◽  
Immune Mediated ◽  
Dose Prednisone

Immunotherapy drugs are associated with a multitude of immune-related adverse events. We describe a case of cardiac tamponade in a patient with stage IV lung adenocarcinoma, with almost 100% expression of PDL-1, treated with pembrolizumab. The patient is a 62-year-old male who developed worsening shortness of breath after five cycles of pembrolizumab. He was diagnosed with large pericardial effusion on computed tomography chest. Echocardiogram confirmed tamponade physiology. He was treated with discontinuation of pembrolizumab and urgent pericardial window followed by high dose prednisone with tapering. The patient responded very well to the treatment. We have comprehensively reviewed cases of pericardial effusion secondary to either immune mediated mechanisms or pseudoprogression.

The Diagnostic Value of Pericardial Fluid and Pericardial Biopsy: Single Center Experiences

2016 ◽  
Vol 19 (1) ◽  
pp. 023 ◽  
Author(s):  
Mehmet Yildirim ◽  
Recep Ustaalioglu ◽  
Murat Erkan ◽  
Bala Basak Oven Ustaalioglu ◽  
Hatice Demirbag ◽  
...  
Keyword(s):  
Pericardial Effusion ◽  
Thoracoscopic Surgery ◽  
Pericardial Tamponade ◽  
Pericardial Fluid ◽  
Pathological Examination ◽  
Common Disease ◽  
Pericardial Window ◽  
Surgical Interventions ◽  
History Of ◽  
Recurrent Pericardial Effusion

<strong>Background:</strong> Patients with recurrent pericardial effusion and pericardial tamponade are usually treated in thoracic surgery clinics by VATS (video-assisted thoracoscopic surgery) or open pericardial window operation. The diagnostic importance of pathological evaluation of the pericardial fluid and tissue in the same patients has been reported in few studies. We reviewed pathological examination of the pericardial tissue and fluid specimens and the effect on the clinical treatment in our clinic, and compared the results with the literature. <br /><strong>Methods:</strong> We retrospectively analyzed 174 patients who underwent pericardial window operation due to pericardial tamponade or recurrent pericardial effusion. For all patients both the results of the pericardial fluid and pericardial biopsy specimen were evaluated. Clinicopathological factors were analyzed by using descriptive analysis. <br /><strong>Results:</strong> Median age was 61 (range, 20-94 years). The most common benign diagnosis was chronic inflammation (94 patients) by pericardial biopsy. History of malignancy was present in 28 patients (16.1%) and the most common disease was lung cancer (14 patients). A total of 24 patients (13.8%) could be diagnosed as having malignancy by pericardial fluid or pericardial biopsy examination. The malignancy was recognized for 12 patients who had a history of cancer; 9 of 12 with pericardial biopsy, 7 diagnosed by pericardial fluid. Twelve of 156 patients were recognized as having underlying malignancy by pericardial biopsy (n = 9) or fluid examination (n = 10), without known malignancy previously. <br /><strong>Conclusion:</strong> Recurrent pericardial effusion/pericardial tamponade are entities frequently diagnosed, and surgical interventions may be needed either for diagnosis and/or treatment, but specific etiology can rarely be obtained in spite of pathological examination of either pericardial tissue or fluid. For increasing the probability of a specific diagnosis both the pericardial fluid and the pericardial tissues have to be sent for pathologic examination.

scholarly journals Pericardial effusion and cardiac tamponade requiring pericardial window in an otherwise healthy 30-year-old patient with COVID-19: a case report

2020 ◽  
Vol 14 (1) ◽  
Author(s):  
Christina Walker ◽  
Vincent Peyko ◽  
Charles Farrell ◽  
Jeanine Awad-Spirtos ◽  
Matthew Adamo ◽  
...  
Keyword(s):  
Case Report ◽  
Pericardial Effusion ◽  
Cardiac Tamponade ◽  
Case Reports ◽  
Healthy Woman ◽  
Signs And Symptoms ◽  
Rare Presentation ◽  
Pericardial Window ◽  
Acute Pericarditis ◽  
Novel Coronavirus

Abstract Background This case report demonstrates pericardial effusion, acute pericarditis, and cardiac tamponade in an otherwise healthy woman who had a positive test result for coronavirus disease 2019. Few case reports have been documented on patients with this presentation, and it is important to share novel presentations of the disease as they are discovered. Case presentation A Caucasian patient with coronavirus disease 2019 returned to the emergency department of our hospital 2 days after her initial visit with worsening chest pain and shortness of breath. Imaging revealed new pericardial effusion since the previous visit. The patient became hypotensive, was taken for pericardial window for cardiac tamponade with a drain placed, and was treated for acute pericarditis. Conclusion Much is still unknown about the implications of coronavirus disease 2019. With the novel coronavirus disease 2019 pandemic, research is still in process, and we are slowly learning about new signs and symptoms of the disease. This case report documents a lesser-known presentation of a patient with coronavirus disease 2019 and will help to further understanding of a rare presentation.

scholarly journals BRASH: Case Report and Review of Literature

Hearts ◽  
2021 ◽  
Vol 2 (3) ◽  
pp. 302-306
Author(s):  
Sauradeep Sarkar ◽  
Nicole Rapista ◽  
Amit Rout ◽  
Rahul Chaudhary
Keyword(s):  
Renal Failure ◽  
Case Report ◽  
Predisposing Factors ◽  
Shortness Of Breath ◽  
Review Of Literature ◽  
Vicious Cycle ◽  
Hypertensive Urgency

BRASH syndrome is characterized by bradycardia, renal failure, AV nodal blockade, shock, and hyperkalemia. The proposed mechanism involves a vicious cycle between AV nodal blockers, hyperkalemia, and renal failure and was first described in 2016. We present a case of a 52-year-old woman who presented with progressively worsening shortness of breath and hypertensive urgency who subsequently developed profound bradycardia and shock that was refractory to resuscitative measures, she was diagnosed with BRASH syndrome. In this article, we explore the predisposing factors and challenges faced during the management of patients with BRASH syndrome.

scholarly journals Clinical features of acute kidney injury in Coronavirus disease 2019—A case report with review of literature

2020 ◽  
Author(s):  
Hai Yuan ◽  
Xiaohan Lu ◽  
E Guo ◽  
Fengqi Hu ◽  
Zhao Gao
Keyword(s):  
Acute Kidney Injury ◽  
Case Report ◽  
Kidney Function ◽  
Kidney Injury ◽  
Hubei Province ◽  
Review Of Literature ◽  
Case Presentation ◽  
High Incidence ◽  
Careful Management ◽  
High Incidence Area

Abstract Background: In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, Hubei province, China. We surveyed 91 patients who were diagnosis as coronavirus disease 2019 (COVID-19) in Xiangyang, Hubei province. And we found the incident of acute kidney injury (AKI) was 3.29% (3/91), which was higher than in the whole country but similar in Hubei province.Case presentation: We describe a case of 58-year-old man who was diagnosis as AKI stage 3 and non-oliguria AKI in the SARS-CoV-2 infection. After antiviral and other supporting treatment, his kidney function improved and he was transferred to normal ward.Conclusions: This case illustrated that careful management and strict monitoring of kidney function should be employed in COVID-19 patients especially in high incidence area of COVID-19.

A Case Report on the Surgical Management of Subhepatic Perforated Appendicitis: A Rare Presentation

2020 ◽  
Author(s):  
Mumin Hakim ◽  
Rania Mostafa ◽  
Mohammed Al Shehri ◽  
Sherif Sharawy
Keyword(s):  
Case Report ◽  
Acute Appendicitis ◽  
Female Patient ◽  
Surgical Management ◽  
Perforated Appendicitis ◽  
Exploratory Laparotomy ◽  
Atypical Presentation ◽  
Review Of Literature ◽  
Rare Presentation ◽  
Case Presentation

Abstract Background: Subhepatic appendicitis is an exceedingly rare presentation accounting for 0.01% of Acute appendicitis. It is of prime importance to be aware of various variants and thereby managing such challenging cases accordingly.Case presentation: We present a middle-aged female patient with subhepatic perforated appendicitis and peritonitis who underwent an exploratory laparotomy and appendectomy.Conclusions: Surgical management of such patients is challenging due to an atypical presentation. The surgical management of such patients is discussed with a brief review of literature.

Recurrent pericardial effusion with pericardial amyloid deposition: a case report and literature review

2020 ◽  
Vol 46 ◽  
pp. 107191
Author(s):  
Hiroko Itagaki ◽  
Tomoko Yamamoto ◽  
Kenta Uto ◽  
Atsuko Hiroi ◽  
Hiromi Onizuka ◽  
...  
Keyword(s):  
Case Report ◽  
Pericardial Effusion ◽  
Literature Review ◽  
Amyloid Deposition ◽  
Recurrent Pericardial Effusion

scholarly journals Hydralazine Induced Lupus Syndrome Presenting with Recurrent Pericardial Effusion and a Negative Antinuclear Antibody

2017 ◽  
Vol 2017 ◽  
pp. 1-3 ◽  
Author(s):  
Praneet Iyer ◽  
Ahmed Dirweesh ◽  
Ritika Zijoo
Keyword(s):  
Pericardial Effusion ◽  
Lupus Erythematosus ◽  
Antinuclear Antibody ◽  
Autoimmune Disorder ◽  
Unique Case ◽  
Drug Induced ◽  
Pericardial Window ◽  
Lupus Syndrome ◽  
Chronic Use ◽  
Recurrent Pericardial Effusion

Drug induced lupus erythematosus (DIL or DILE) is an autoimmune disorder caused by chronic use of certain drugs. We report a unique case of hydralazine induced lupus syndrome (HILS) with a negative antinuclear antibody in a female patient who was on hydralazine for a period of 1.5–2 years and developed recurrent pericardial effusion as a result of it. Initially her condition was managed with a pericardial window. The recurrence of a massive pericardial effusion necessitated a right hemipericardiectomy. After hydralazine was stopped, she never had any further episodes of pericardial effusion or tamponade.

scholarly journals A Case of Non-Hodgkin's Lymphoma with Recurrent Pericardial Effusion and Chest wall Mass

1970 ◽  
Vol 17 (2) ◽  
pp. 138-141 ◽  
Author(s):  
MB Alam ◽  
R Dasgupta ◽  
S Ahmed ◽  
MAR Ferdous
Keyword(s):  
Pericardial Effusion ◽  
Chest Wall ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Severe Respiratory Distress ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Wall Mass ◽  
Recurrent Pericardial Effusion ◽  
Chest Wall Mass

Recurrent pericardial effusion as a presenting feature of Non-Hodgkin's Lymphoma is uncommon. Here we describe the case of an 18-year-old male presented with severe respiratory distress with a chest wall swelling. During the course of his three months illness, he was hospitalized two times with few days interval for similar attack of dyspnoea without any chest wall mass. Each time there was pericardial effusion and pericardiocentesis was done but no conclusive diagnosis could be made. Finally, when he came to us with a chest wall mass in addition to pericardial effusion, Non-Hodgkin's Lymphoma was confirmed by FNAC of that mass. Symptomatic improvement was achieved after first cycle of chemotherapy with CHOP. Keywords: Non-Hodgkin's lymphoma; recurrent pericardial effusion; chest wall mass. DOI: 10.3329/jdmc.v17i2.6599J Dhaka Med Coll. 2008; 17(2) : 138-141

Sign in / Sign up

Export Citation Format

Share Document